ArticleHaematologica2024

Integration of genotypic data into clinical trial design and reporting in hereditary hemorrhagic telangiectasia could help personalize treatment.

Atieh Modarresi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.